Jimmi Nielsen
Clinical Professor
There is no presentation filled.
ID: 217143987
Most downloads
-
41
downloads
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
20
downloads
Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
17
downloads
Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine-or Olanzapine-Treated, Prediabetic, Schizophrenia Patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published